InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by BOBULSKY SUSAN. Director active across 1 company, notably Adaptive Biotechnologies Corp. In total, 3 reports have been published. Activity tracked since 4 March 2024. The latest transaction was disclosed on 4 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
3 of 3 declarations